Wright Beats, Books Small Profit - Analyst Blog
February 24 2012 - 5:00AM
Zacks
Orthopedic devices maker,
Wright Medical Group (WMGI) reported fourth
quarter and fiscal 2011 adjusted (excluding one-time items other
than stock-based compensation expense) earnings per share of 13
cents and 70 cents, respectively, beating the corresponding Zacks
Consensus Estimates of 11 cents and 66 cents.
The company reported minor net
income of $1.2 million (or 3 cents per share) in the reported
quarter. Net income for the quarter included $3.4 million of
expenditure associated with Wright Medical’s deferred prosecution
agreement, $2.8 million of expenses in conjunction with the
previously disclosed cost restructuring plan, $2.4 million of stock
based compensation expense and $1 million of income tax provision
for an estimated IRS audit liability.
Revenues
Net sales for the quarter were
$126.9 million, down 8% year over year in reported terms (down 9%
on a constant currency basis), beating the Zacks Consensus Estimate
of $123 million. In fiscal 2011, net sales were $512.9 million,
down 1.2% year over year, ahead of the Zacks Consensus Estimate of
$510 million.
Revenues from the domestic market
totaled $73.3 million (57.8% of total sales), down 9.7% year over
year. Domestic sales were negatively impacted by earlier announced
distributor transitions, which occurred in the third quarter and
issues connected with implementing enhancement to Wright Medical’s
compliance systems. International revenues declined 6.1% (down 8%
in constant currency) to $53.6 million (42.2% of sales).
Segment-wise
Results
Wright Medical reports sales in
four major segments, namely Hip, Knee, Extremity and Biologics,
which accounted for 34%, 24%, 28% and 12%, respectively, of net
revenues for the quarter.
Hip product revenues dropped 9%
year over year in constant currency while Knee sales shrunk 13% in
the quarter. Extremity recorded a modest 4% growth. Biologics sales
slipped 22% in constant currency.
Margins
Adjusted operating income was $12.8
million in the reported quarter, approximately down 33.3% year over
year. Adjusted operating margin was 10.1%, lower than 13.9% in the
year-ago quarter.
Balance Sheet
Cash, cash equivalents and
marketable securities totaled $167.2 million, down 3% year over
year. Long-term obligations stood at $167 million, as of December
31, 2011, down 17.3% year over year.
Outlook
Wright Medical forecasts net sales
in a band of $472 million to $489 million for fiscal 2012. The
company projects adjusted earnings per share, for fiscal 2012, in
the range of 26 cents to 36 cents per share. Adjusted earnings for
fiscal 2012 excludes expenses associated with cost restructuring,
non-compete and transition costs with regard to converting a
substantial portion of independent foot and ankle areas to direct,
potential future acquisitions, costs associated with the deferred
prosecution agreement, stock-based compensation expense and certain
other contingencies.
Wright Medical forecasts that
non-cash, stock-based compensation charge will be about 18 cents
per share for fiscal 2012. Consequently, adjusted earnings per
share, including stock-based compensation, is estimated in a band
of 8 cents and 18 cents.
Our views are moderated by intense
competition from larger players and pricing pressure. Wright
Medical competes with much bigger names such as Zimmer
Holdings (ZMH), Stryker (SYK) and
Smith & Nephew (SNN). We are currently Neutral
on the stock, backed by a short-term Zacks #3 Rank (Hold).
SMITH & NEPHEW (SNN): Free Stock Analysis Report
STRYKER CORP (SYK): Free Stock Analysis Report
WRIGHT MEDICAL (WMGI): Free Stock Analysis Report
ZIMMER HOLDINGS (ZMH): Free Stock Analysis Report
To read this article on Zacks.com click here.
Zacks Investment Research
Stryker (NYSE:SYK)
Historical Stock Chart
From Aug 2024 to Sep 2024
Stryker (NYSE:SYK)
Historical Stock Chart
From Sep 2023 to Sep 2024